Healthcare Jul 05, 2021 09:30 PM (GMT+8)
Fangsheng pharmaceutical announced that the company signed equity transfer agreement with Boda development, yuanhuixuan consulting and changyixing investment, and transferred 100% equity of Jiangxi tengwangge Pharmaceutical Co., Ltd. with 176 million yuan. The core asset of tengwangge pharmaceutical is that it has 32 drug approval numbers (specifications) for all kinds of products with "tengwangge" as the registered trademark, mainly involving cough and phlegm relieving, heat clearing and detoxification, tonic, pediatric medicine, etc. This transaction will help the company expand the coverage of common diseases and commonly used drugs.
This text is a result of machine translation.